Status:
UNKNOWN
Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos
Lead Sponsor:
Lahore General Hospital
Conditions:
Vaccine Reaction
Eligibility:
All Genders
Brief Summary
In most parts of the world, mRNA vaccines were used to provide protection to population against COVID 19. However, in some countries, including Pakistan, traditional viral vaccines named as Sinovac an...
Detailed Description
In most parts of the world, mRNA vaccines were used to provide protection to population against COVID 19. However, in some countries, including Pakistan, traditional viral vaccines named as Sinovac an...
Eligibility Criteria
Inclusion
- people who have received two doses of sinopharm or sinovac and six months have passed after the second dose
Exclusion
- people getting one shot of sinopharm or sinovac or got vaccine other than sinopharm and sinovac.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05213455
Start Date
January 1 2022
End Date
March 15 2022
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahore General Hospital
Lahore, Punjab Province, Pakistan, 57000